Ignite Creation Date:
2024-05-05 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 9:54 AM
Study NCT ID:
NCT00750152
Status:
COMPLETED
Last Update Posted:
2013-04-22
First Post:
2008-09-09
Brief Title:
Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris
Sponsor:
Merz North America Inc
Organization:
Merz North America Inc
Study Overview
Official Title:
A Phase 3 Double-Blind Randomized Placebo-ControlledMulticenter Parallel Group Evaluation of the Efficacy and Safety of NAFT-500 in Subjects With Tinea Cruris
Status:
COMPLETED
Status Verified Date:
2012-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A research study to compare the safety and effectiveness of an investigational medication called NAFT-500 to placebo no active treatment when used in subjects with tinea cruris also known as jock itch
Detailed Description:
To evaluate the efficacy and safety of NAFT-500 applied once daily for 2 weeks compared to placebo in the treatment of subjects with potassium hydroxide KOH and culture positive symptomatic tinea cruris
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None